Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Limitations, lack of standardization, and recommended best practices in studies of renewable energy effects on birds and bats.

Conkling TJ, Loss SR, Diffendorfer JE, Duerr A, Katzner TE.

Conserv Biol. 2020 Jan 8. doi: 10.1111/cobi.13457. [Epub ahead of print] Review.

PMID:
31913528
2.

Wind energy: An ecological challenge.

Katzner TE, Nelson DM, Diffendorfer JE, Duerr AE, Campbell CJ, Leslie D, Vander Zanden HB, Yee JL, Sur M, Huso MMP, Braham MA, Morrison ML, Loss SR, Poessel SA, Conkling TJ, Miller TA.

Science. 2019 Dec 6;366(6470):1206-1207. doi: 10.1126/science.aaz9989. No abstract available.

PMID:
31806806
3.

HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru.

Trebelcock WL, Lama JR, Duerr A, Sanchez H, Cabello R, Gilada T, Segura P, Reisner SL, Mayer KH, Mullins J, Bender Ignacio RA.

J Int AIDS Soc. 2019 Nov;22(11):e25411. doi: 10.1002/jia2.25411.

4.

HIV self-testing in Pune, India: perspectives and recommendations of female sex workers and peer educators.

Chang YM, Sevekari T, Duerr A, Molina Y, Gilada T.

AIDS Care. 2020 Feb;32(2):182-185. doi: 10.1080/09540121.2019.1683804. Epub 2019 Oct 31.

PMID:
31672026
5.

Correlates of concurrent partnerships and patterns of condom use among men who have sex with men and transgender women in Peru.

Ulrich AK, Sanchez J, Lama JR, Manhart LE, Goodreau SM, Duerr AC.

PLoS One. 2019 Sep 16;14(9):e0222114. doi: 10.1371/journal.pone.0222114. eCollection 2019.

6.

Characterizing Men Who Have Sex with Transgender Women in Lima, Peru: Sexual Behavior and Partnership Profiles.

Long JE, Ulrich A, White E, Dasgupta S, Cabello R, Sanchez H, Lama JR, Duerr A.

AIDS Behav. 2019 Jul 12. doi: 10.1007/s10461-019-02590-w. [Epub ahead of print]

PMID:
31300977
7.

Increasing PrEP uptake and adherence among MSM and TW sex workers in Lima, Perú: what and whom do different patients trust?

Longino A, Montano MA, Sanchez H, Bayer A, Sanchez J, Tossas-Milligan K, Duerr A, Molina Y.

AIDS Care. 2020 Feb;32(2):255-260. doi: 10.1080/09540121.2019.1634787. Epub 2019 Jun 26.

PMID:
31242753
8.

Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation.

Bender Ignacio RA, Dasgupta S, Stevens-Ayers T, Kula T, Hill JA, Lee SJ, Mielcarek M, Duerr A, Elledge SJ, Boeckh M.

Blood. 2019 Aug 8;134(6):503-514. doi: 10.1182/blood.2019897405. Epub 2019 Jun 11.

9.

Perceptions Prediagnosis and Social Experiences Postdiagnosis Among a Sample of High-Risk Peruvian Men Who Have Sex With Men.

Molina Y, Konda KA, Sanchez H, de la Grecca R, Villarán M, Rios J, Bain CE, Greer A, Wandell G, Lama JR, Duerr A.

Stigma Health. 2019 May;4(2):204-212. doi: 10.1037/sah0000111. Epub 2018 May 14.

10.

Differences in sexually transmitted infection risk comparing preexposure prophylaxis users and propensity score matched historical controls in a clinic setting.

Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Manhart LE, Barbee LA, Duerr A, Khosropour CM.

AIDS. 2019 Sep 1;33(11):1773-1780. doi: 10.1097/QAD.0000000000002281.

PMID:
31149948
11.

Demographic and risk group heterogeneity across the UNAIDS 90-90-90 targets: a systematic review and meta-analysis protocol.

Green D, Kharono B, Tordoff DM, Akullian A, Bershteyn A, Morrison M, Garnett G, Duerr A, Drain P.

Syst Rev. 2019 May 6;8(1):110. doi: 10.1186/s13643-019-1024-6.

12.

Projected effectiveness of HIV detection during early infection and rapid ART initiation among MSM and transgender women in Peru: A modeling study.

Dimitrov D, Wood D, Ulrich A, Swan DA, Adamson B, Lama JR, Sanchez J, Duerr A.

Infect Dis Model. 2019 Apr 6;4:73-82. doi: 10.1016/j.idm.2019.04.001. eCollection 2019.

13.

Correction to: Experienced HIV-Related Stigma and Psychological Distress in Peruvian Sexual and Gender Minorities: A Longitudinal Study to Explore Mediating Roles of Internalized HIV-Related Stigma and Coping Styles.

Rinehart R, Rao D, Amico RK, Ruiz E, Brandes P, Correa C, Pasalar S, Lama JR, Duerr A, Molina Y.

AIDS Behav. 2019 Mar;23(3):675. doi: 10.1007/s10461-019-02394-y.

PMID:
30734210
14.

Brief Report: Comparing Sexual Risk Behavior in a High-Risk Group of Men Who Have Sex With Men and Transgender Women in Lima, Peru.

Long JE, Montaño M, Cabello R, Sanchez H, Lama JR, Duerr A.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):522-526. doi: 10.1097/QAI.0000000000001966.

PMID:
30664074
15.

Impact of pre-diagnosis awareness of HIV-related stigma and dispositional coping on linkage to HIV care among newly diagnosed HIV+ Peruvian patients.

Molina Y, Ulrich A, Greer AC, Primbas A, Wandell G, Sanchez H, Bain C, Konda KA, Clark JL, De la Grecca R, Villarán MV, Pasalar S, Lama JR, Duerr AC.

AIDS Care. 2019 Jul;31(7):848-856. doi: 10.1080/09540121.2018.1563282. Epub 2019 Jan 7.

PMID:
30616376
16.

Experienced HIV-Related Stigma and Psychological Distress in Peruvian Sexual and Gender Minorities: A Longitudinal Study to Explore Mediating Roles of Internalized HIV-Related Stigma and Coping Styles.

Rinehart R, Rao D, Amico RK, Ruiz E, Brandes P, Correa C, Pasalar S, Lama JR, Duerr A, Molina Y.

AIDS Behav. 2019 Mar;23(3):661-674. doi: 10.1007/s10461-018-2348-2. Erratum in: AIDS Behav. 2019 Feb 7;:.

17.

Changes in Sexual Behavior and STI Diagnoses Among MSM Initiating PrEP in a Clinic Setting.

Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart LE, Barbee LA, Khosropour CM.

AIDS Behav. 2019 Feb;23(2):548-555. doi: 10.1007/s10461-018-2252-9.

PMID:
30117076
18.

Design Strategy of the Sabes Study: Diagnosis and Treatment of Early HIV Infection Among Men Who Have Sex With Men and Transgender Women in Lima, Peru, 2013-2017.

Lama JR, Brezak A, Dobbins JG, Sanchez H, Cabello R, Rios J, Bain C, Ulrich A, De la Grecca R, Sanchez J, Duerr A.

Am J Epidemiol. 2018 Aug 1;187(8):1577-1585. doi: 10.1093/aje/kwy030. Erratum in: Am J Epidemiol. 2018 Aug 1;187(8):1828.

19.

Computational analysis of antibody dynamics identifies recent HIV-1 infection.

Seaton KE, Vandergrift NA, Deal AW, Rountree W, Bainbridge J, Grebe E, Anderson DA, Sawant S, Shen X, Yates NL, Denny TN, Liao HX, Haynes BF, Robb ML, Parkin N, Santos BR, Garrett N, Price MA, Naniche D, Duerr AC; CEPHIA group, Keating S, Hampton D, Facente S, Marson K, Welte A, Pilcher CD, Cohen MS, Tomaras GD.

JCI Insight. 2017 Dec 21;2(24). pii: 94355. doi: 10.1172/jci.insight.94355.

20.

A Qualitative Assessment of Alcohol Consumption and Sexual Risk Behaviors Among Men Who Have Sex With Men and Transgender Women in Peru.

Vagenas P, Brown SE, Clark JL, Konda KA, Lama JR, Sánchez J, Duerr AC, Altice FL.

Subst Use Misuse. 2017 Jun 7;52(7):831-839. doi: 10.1080/10826084.2016.1264968. Epub 2017 Feb 7.

21.

Knowledge and preferences concerning acute HIV testing programs among both Peruvian men who have sex with men and transgender women.

Wandell GM, Molina Y, Sánchez H, Greer AC, Ríos J, Bain C, Segura P, Lama JR, Sánchez J, Duerr A.

Int J STD AIDS. 2017 Sep;28(10):1010-1017. doi: 10.1177/0956462416685674. Epub 2017 Jan 6.

22.

Golden Eagle fatalities and the continental-scale consequences of local wind-energy generation.

Katzner TE, Nelson DM, Braham MA, Doyle JM, Fernandez NB, Duerr AE, Bloom PH, Fitzpatrick MC, Miller TA, Culver RC, Braswell L, DeWoody JA.

Conserv Biol. 2017 Apr;31(2):406-415. doi: 10.1111/cobi.12836. Epub 2016 Sep 27.

PMID:
27677518
23.

Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition.

Hayes PJ, Cox JH, Coleman AR, Fernandez N, Bergin PJ, Kopycinski JT, Nitayaphan S, Pitisuttihum P, de Souza M, Duerr A, Morgan C, Gilmour JW.

AIDS. 2016 Jul 17;30(11):1703-12. doi: 10.1097/QAD.0000000000001122.

24.

Use of multiple modes of flight subsidy by a soaring terrestrial bird, the golden eagle Aquila chrysaetos, when on migration.

Katzner TE, Turk PJ, Duerr AE, Miller TA, Lanzone MJ, Cooper JL, Brandes D, Tremblay JA, Lemaître J.

J R Soc Interface. 2015 Nov 6;12(112). pii: 20150530. doi: 10.1098/rsif.2015.0530.

25.

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.

Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME, Kublin JG, Robertson M, Hammer SM, Gray GE, Buchbinder SP, Gilbert PB.

PLoS One. 2015 Sep 2;10(9):e0136626. doi: 10.1371/journal.pone.0136626. eCollection 2015.

26.

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders.

Janes H, Herbeck JT, Tovanabutra S, Thomas R, Frahm N, Duerr A, Hural J, Corey L, Self SG, Buchbinder SP, McElrath MJ, O'Connell RJ, Paris RM, Rerks-Ngarm S, Nitayaphan S, Pitisuttihum P, Kaewkungwal J, Robb ML, Michael NL, Mullins JI, Kim JH, Gilbert PB, Rolland M.

Nat Med. 2015 Oct;21(10):1139-41. doi: 10.1038/nm.3932. Epub 2015 Aug 31.

27.

Chronic lead exposure is epidemic in obligate scavenger populations in eastern North America.

Behmke S, Fallon J, Duerr AE, Lehner A, Buchweitz J, Katzner T.

Environ Int. 2015 Jun;79:51-5. doi: 10.1016/j.envint.2015.03.010. Epub 2015 Mar 19.

PMID:
25795925
28.

Men Who Have Sex With Men in Peru: Acceptability of Medication-Assisted Therapy for Treating Alcohol Use Disorders.

Brown SE, Vagenas P, Konda KA, Clark JL, Lama JR, Gonzales P, Sanchez J, Duerr AC, Altice FL.

Am J Mens Health. 2017 Jul;11(4):1269-1278. doi: 10.1177/1557988315576775. Epub 2015 Mar 17.

29.

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study.

Huang Y, Duerr A, Frahm N, Zhang L, Moodie Z, De Rosa S, McElrath MJ, Gilbert PB.

PLoS One. 2014 Nov 4;9(11):e108631. doi: 10.1371/journal.pone.0108631. eCollection 2014.

30.

Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease.

Müller HP, Kassubek J, Grön G, Sprengelmeyer R, Ludolph AC, Klöppel S, Hobbs NZ, Roos RA, Duerr A, Tabrizi SJ, Orth M, Süssmuth SD, Landwehrmeyer GB.

Biomed Eng Online. 2014 Sep 1;13:128. doi: 10.1186/1475-925X-13-128.

31.

Assessing risk to birds from industrial wind energy development via paired resource selection models.

Miller TA, Brooks RP, Lanzone M, Brandes D, Cooper J, O'Malley K, Maisonneuve C, Tremblay J, Duerr A, Katzner T.

Conserv Biol. 2014 Jun;28(3):745-55. doi: 10.1111/cobi.12227. Epub 2014 Jan 9.

PMID:
24405249
32.

Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach.

Müller HP, Grön G, Sprengelmeyer R, Kassubek J, Ludolph AC, Hobbs N, Cole J, Roos RA, Duerr A, Tabrizi SJ, Landwehrmeyer GB, Süssmuth SD.

Neuroimage Clin. 2013 Jan 3;2:161-7. doi: 10.1016/j.nicl.2012.12.005. eCollection 2013.

33.

Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner.

Semprini AE, Macaluso M, Hollander L, Vucetich A, Duerr A, Mor G, Ravizza M, Jamieson DJ.

Am J Obstet Gynecol. 2013 May;208(5):402.e1-9. doi: 10.1016/j.ajog.2013.02.009. Epub 2013 Feb 8.

PMID:
23395921
34.

Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus.

McElrath MJ, Smythe K, Randolph-Habecker J, Melton KR, Goodpaster TA, Hughes SM, Mack M, Sato A, Diaz G, Steinbach G, Novak RM, Curlin ME, Lord JD, Maenza J, Duerr A, Frahm N, Hladik F; NIAID HIV Vaccine Trials Network.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):263-71. doi: 10.1097/QAI.0b013e3182898392. Erratum in: J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):323. Curlin, M [corrected to Curlin, Marcel E].

35.

Reply to Richie and Villasante.

Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Huang Y, Gilbert P, Corey L, Robertson MN.

J Infect Dis. 2013 Feb 15;207(4):690-2. doi: 10.1093/infdis/jis738. Epub 2012 Nov 29. No abstract available.

36.

Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity.

Zak DE, Andersen-Nissen E, Peterson ER, Sato A, Hamilton MK, Borgerding J, Krishnamurty AT, Chang JT, Adams DJ, Hensley TR, Salter AI, Morgan CA, Duerr AC, De Rosa SC, Aderem A, McElrath MJ.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3503-12. doi: 10.1073/pnas.1208972109. Epub 2012 Nov 14.

37.

Antiretroviral treatment in resource-limited settings 2012.

Duerr A, Altice FL, Harries AD, Sohn AH.

AIDS Res Treat. 2012;2012:346708. doi: 10.1155/2012/346708. Epub 2012 Jul 25. No abstract available.

38.

Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).

Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; Step/HVTN 504 Study Team.

J Infect Dis. 2012 Jul 15;206(2):258-66. doi: 10.1093/infdis/jis342. Epub 2012 May 4.

39.

Testing an emerging paradigm in migration ecology shows surprising differences in efficiency between flight modes.

Duerr AE, Miller TA, Lanzone M, Brandes D, Cooper J, O'Malley K, Maisonneuve C, Tremblay J, Katzner T.

PLoS One. 2012;7(4):e35548. doi: 10.1371/journal.pone.0035548. Epub 2012 Apr 25.

40.

HIV treatment as prevention: [corrected] next steps.

Duerr A.

Curr Opin HIV AIDS. 2012 Mar;7(2):97-8. doi: 10.1097/COH.0b013e328350579a. No abstract available. Erratum in: Curr Opin HIV AIDS. 2012 May;7(3):289.

PMID:
22241162
41.

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.

Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ.

J Clin Invest. 2012 Jan;122(1):359-67. doi: 10.1172/JCI60202. Epub 2011 Dec 27.

42.

Comparing Measures of Late HIV Diagnosis in Washington State.

Saganic L, Carr J, Solorio R, Courogen M, Jaenicke T, Duerr A.

AIDS Res Treat. 2012;2012:182672. doi: 10.1155/2012/182672. Epub 2011 Nov 15.

43.

Frequencies of IL10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais.

Kingkeow D, McNicholl JM, Maneekarn N, Wongtrakul J, Taechareonkul S, Suriyanon V, Nelson KE, Duerr A, Makonkawkeyoon S.

Asian Pac J Allergy Immunol. 2011 Mar;29(1):94-101.

44.

Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.

Migueles SA, Rood JE, Berkley AM, Guo T, Mendoza D, Patamawenu A, Hallahan CW, Cogliano NA, Frahm N, Duerr A, McElrath MJ, Connors M.

PLoS Pathog. 2011 Feb;7(2):e1002002. doi: 10.1371/journal.ppat.1002002. Epub 2011 Feb 24.

45.

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.

Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J, Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI.

Nat Med. 2011 Mar;17(3):366-71. doi: 10.1038/nm.2316. Epub 2011 Feb 27.

46.

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).

Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D, Duerr A; Step Study Protocol Team.

J Infect Dis. 2011 Mar 15;203(6):765-72. doi: 10.1093/infdis/jiq114.

47.

Assessing male condom failure and incorrect use.

Duerr A, Gallo MF, Warner L, Jamieson DJ, Kulczycki A, Macaluso M.

Sex Transm Dis. 2011 Jul;38(7):580-6. doi: 10.1097/OLQ.0b013e3182096b62.

PMID:
21278626
48.

Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study.

Curlin ME, Cassis-Ghavami F, Magaret AS, Spies GA, Duerr A, Celum CL, Sanchez JL, Margolick JB, Detels R, McElrath MJ, Corey L.

AIDS. 2011 Jan 14;25(2):153-8. doi: 10.1097/QAD.0b013e328342115c.

49.

Update on mucosal HIV vaccine vectors.

Duerr A.

Curr Opin HIV AIDS. 2010 Sep;5(5):397-403. doi: 10.1097/COH.0b013e32833d2e39. Review.

PMID:
20978380
50.

Supplemental Content

Support Center